DPI Research

The influenza vaccines market in the United States is poised for considerable growth, with an estimated market value approaching $4.78 billion in 2024.

DPI Research has published the latest report on insulin pen market and forecast to its offering

The global diabetes insulin delivery pen market size was valued at USD 17.7 Billion in 2023 and is likely to reach USD 28.7 Billion in 2032, expanding at a CAGR 5.5% during the forecast period.

The global influenza vaccines market size was valued at USD 7.8 Billion in 2023 and is likely to reach USD 13.7 Billion in 2032, expanding at a CAGR 7.2% during the forecast period.

Market dynamics indicate a continued expansion in the NIPT sector, with forecasts suggesting that the market could reach approximately US$ 2.8 billion by 2033 representing a compound annual growth rate (CAGR) of approximately 10.5% from 2025 – 2033

This growth is expected to continue, with projections indicating that the market could reach around US$ 9.66 billion by 2033, representing a compound annual growth rate (CAGR) of approximately 8% from 2025 – 2033.

Market dynamics indicate a continued expansion in the NIPT sector, with forecasts suggesting that the market could reach approximately US$ 2.8 billion by 2033 representing a compound annual growth rate (CAGR) of approximately 10.5% from 2025 - 2033

Market dynamics indicate a continued expansion in the NIPT sector, with forecasts suggesting that the market could reach approximately US$ 2.8 billion by 2033 representing a compound annual growth rate (CAGR) of approximately 10.5% from 2025 – 2033

Market dynamics indicate continued expansion in the NIPT sector, with forecasts suggesting that the market could reach approximately US$ 2.8 billion by 2033 representing a compound annual growth rate (CAGR) of approximately 10.5% from 2025 – 2033.

The non-invasive prenatal testing (NIPT) market in the United States has experienced remarkable growth over recent years, reflecting an increasing awareness and acceptance of advanced prenatal screening technologies.